CYPS

Cyclo3pss Corporation CYPS

CYPS
Cyclo3pss Corporation THCT
THC Therapeutics, Inc. NMRD
Nemaura Medical Inc. TNGNQ
Tengion, Inc. REMI
Remedent, Inc. UPH
UpHealth, Inc. VIVE
Viveve Medical, Inc. CVHIF
Ventura Cannabis & Wellness Corporation EMGE
Emergent Health Corp KLDO
Kaleido Biosciences, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CYPS THCT NMRD TNGNQ REMI UPH VIVE CVHIF EMGE KLDO
6M -50.00 % 300.00 % 0.00 % 900.00 % -94.00 % -81.93 % 0.00 % 0.00 % -50.00 % 0.00 %
YTD -50.00 % -55.56 % 0.00 % 900.00 % -99.00 % 25.65 % -50.00 % 0.00 % -88.76 % 0.00 %
1Y -50.00 % -42.86 % -50.00 % 900.00 % -99.00 % -87.29 % -50.00 % 0.00 % -87.50 % 0.00 %
3Y -98.00 % -6.51 % -99.99 % 9 900.00 % -99.65 % -99.72 % -100.00 % 900.00 % -97.50 % -90.91 %
5Y -99.68 % -79.56 % -100.00 % 9 900.00 % -99.70 % -99.69 % -100.00 % -96.00 % -99.94 % -100.00 %
10Y -98.00 % -97.05 % -100.00 % 9 900.00 % -99.65 % -99.69 % -100.00 % -99.99 % -99.81 % -100.00 %
From the beginning -99.09 % -97.05 % -100.00 % 9 900.00 % -99.98 % -99.69 % -100.00 % -100.00 % -99.99 % -100.00 %

Dividend